Melinta
FDA Rejects Application for Cefepime-Taniborbactam
The FDA issued a Complete Response Letter regarding the new drug application for cefepime-taniborbactam under ...
FEBRUARY 26, 2024
Solutions to AMR, ‘The Silent Pandemic,’ Remain Out of Reach
This used to be the plot of science fiction movies: A virulent organism with no known cure quickly circles the ...
AUGUST 23, 2023
Melinta Therapeutics Acquires Infectious Disease Business From The Medicines Company
The acquisition includes three marketed products: recently approved and launched Vabomere, and established ...
DECEMBER 1, 2017
FDA Approves Baxdela for Acute Bacterial Skin and Skin Structure Infections
Delafloxacin is a fluoroquinolone that exhibits activity against both gram-positive and gram-negative pathogens, ...
JUNE 26, 2017
Load more